Q3 2022 Theriva Biologics Inc Earnings Call Transcript

Nov 11, 2022 / 01:30PM GMT
Operator

Good day, and welcome to Theriva Biologics, formerly Synthetic Biologics, 2022 third quarter operational highlights and financial results. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Chris Calabrese, LifeSci Advisors Relationship Manager. Please go ahead, sir.

Chris Calabrese -

Thank you, operator, and good morning, everyone. Welcome to the Theriva Biologics 2022 Third Quarter Investor Conference Call. Leading the call today will be Steven Shallcross, Chief Executive and Chief Financial Officer of Theriva Biologics. Dr. Manel Cascalló, General Director of Theriva Biologics European subsidiary; Dr. Frank Tufaro, Chief Operating Officer; and Dr. Vince Wacher, Head of Corporate and Product Development of Theriva Biologics, are also on the call and will be available to answer questions during the Q&A session.

Theriva Biologics issued a press release last evening, which provided operational highlights and included the financial results for the third quarter ending September 30, 2022. The press release can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot